{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Ftreatment-of-her2pos-gea-and-btc-rQi8W8yC","width":444,"version":"1.0","type":"rich","title":"HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/781c1a52-4660-4634-9034-219564f23844/101100-her2-btc-gea-ci-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/aebba856-eedd-4256-81c1-bde29e36bc86\" height=\"200\" width=\"100%\" title=\"HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancers: Testing Recommendations and New Treatment Options\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Amit Mahipal, MD, MPH, and Shubham Pant, MD, discuss the new and emerging therapies for the personalized care of patients with HER2-positive gastroesophageal adenocarcinoma and biliary tract cancer."}